Analytes titrated in arthralgic and non arthralgic patients 36 months after the acute phase.
Clémentine Schilte(Inserm), Alain Michault(Centre Hospitalier Universitaire de La Réunion), Yoann Madec(Institut Pasteur), Somar Kassab(Centre Hospitalier Universitaire de La Réunion), Thérèse Couderc(Inserm), Marc Lecuit(Inserm), Frédérik Staikovsky(Centre Hospitalier Universitaire de La Réunion), Carpentier Florence
Cited by 0
Related Papers
A Mouse Model for Chikungunya: Young Age and Inefficient Type-I Interferon Signaling Are Risk Factors for Severe Disease
|PLoS Pathogens|2008|610
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study
|The Lancet Infectious Diseases|2017|587
Multidisciplinary Prospective Study of Mother-to-Child Chikungunya Virus Infections on the Island of La Réunion
|PLoS Medicine|2008|511
Chikungunya Virus-associated Long-term Arthralgia: A 36-month Prospective Longitudinal Study
|PLoS neglected tropical diseases|2013|494
Type I IFN controls chikungunya virus via its action on nonhematopoietic cells
|The Journal of Experimental Medicine|2010|314